Aktuelle Urologie最新文献_第8页

[Angioembolization of Renal Hemorrhage]. 【肾出血血管栓塞术】。

IF 0.4 4区医学

Aktuelle Urologie Pub Date : 2026-04-01 Epub Date: 2026-02-06 DOI: 10.1055/a-2782-5350

Jan-Peter Roth

{"title":"[Angioembolization of Renal Hemorrhage].","authors":"Jan-Peter Roth","doi":"10.1055/a-2782-5350","DOIUrl":"10.1055/a-2782-5350","url":null,"abstract":"The therapeutic approach to renal hemorrhage has changed in recent decades. In the past, renal trauma was primarily managed by surgical intervention, whereas non-operative management is increasingly preferred today. This shift is largely attributable to improved diagnostic options, particularly multiphase computed tomography, and to the growing availability and use of angioembolization in the treatment of renal hemorrhage. Regardless of the etiology of renal hemorrhage, the CT-based detection of contrast extravasation, a pseudoaneurysm, or an arteriovenous fistula has been described as a predictive factor for the successful use of selective angioembolization in hemodynamically stable patients. The availability of a wide range of different catheters and embolization materials enables interventional radiologists to treat the underlying renal pathology in a minimally-invasive and superselective manner via the arterial vascular system, thereby preserving healthy renal parenchyma and renal function to the greatest extent possible. A key outcome of the increasing use of selective angioembolization in the management of renal hemorrhage is a significant reduction in nephrectomy rates. In due consideration of the limitations of the technique, angioembolization represents an effective and safe procedure that has firmly established itself as an important approach in the non-operative management of renal hemorrhage.","PeriodicalId":7513,"journal":{"name":"Aktuelle Urologie","volume":" ","pages":"172-183"},"PeriodicalIF":0.4,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146130901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[CT-Guided Interstitial Brachytherapy for Renal Tumours: A Narrative Review of Technique, Evidence, and Clinical Perspectives]. [ct引导下肾肿瘤间质近距离放射治疗：技术、证据和临床观点的叙述回顾]。

IF 0.5 4区医学

Aktuelle Urologie Pub Date : 2026-04-01 Epub Date: 2026-01-07 DOI: 10.1055/a-2750-5393

Paul Rogowski, Maurice Heimer, Frederik Fuchs, Jens Ricke

引用次数: 0

[The Current Status of Prostate Artery Embolization (PAE) for the Treatment of Benign Prostatic Hyperplasia (BPH)]. 前列腺动脉栓塞（PAE）治疗良性前列腺增生（BPH）的现状。

IF 0.5 4区医学

Aktuelle Urologie Pub Date : 2026-04-01 Epub Date: 2026-02-17 DOI: 10.1055/a-2787-4392

Christian R Habermann, Nando Mertineit

{"title":"[The Current Status of Prostate Artery Embolization (PAE) for the Treatment of Benign Prostatic Hyperplasia (BPH)].","authors":"Christian R Habermann, Nando Mertineit","doi":"10.1055/a-2787-4392","DOIUrl":"10.1055/a-2787-4392","url":null,"abstract":"Prostatic artery embolization (PAE) has become established as a minimally invasive treatment option for benign prostatic hyperplasia (BPH) in recent years. This review aims to provide a coherent overview of the technical principles, patient selection, clinical efficacy, safety, health-economic aspects, and guideline positioning. Prospective studies and meta-analyses demonstrate a significant reduction in lower urinary tract symptoms, improvements in quality of life, and relevant prostate volume reduction. Compared with TUR-P and HoLEP, gains in maximum urinary flow are more moderate, whereas periprocedural risks are lower and preservation of antegrade ejaculation is more frequently achieved. Mid-term reintervention rates are higher and should be addressed during patient counseling. PAE is particularly attractive for patients with large prostate volumes, relevant comorbidities, or ongoing anticoagulation. From a technical perspective, non-resorbable particles (100-500 µm) are commonly used, while liquid embolic agents (e.g., Glubran) are employed in selected centers and require further clinical evaluation. Performing PAE in experienced centers with CBCT-guided navigation, standardized protocols, and interdisciplinary decision-making reduces procedural risks and improves clinical outcomes. Overall, PAE meaningfully complements the therapeutic armamentarium for BPH; its future role will depend on robust long-term data, a standardized technique, and more precise positioning within clinical guidelines.","PeriodicalId":7513,"journal":{"name":"Aktuelle Urologie","volume":" ","pages":"161-171"},"PeriodicalIF":0.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146211771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Erstlinientherapie des mCRPC nach alleiniger ADT Vortherapie ± Docetaxel für mCSPC/mHSPC. mCSPC/mHSPC的ADT预后一线治疗±多西他赛。

IF 0.4 4区医学

Aktuelle Urologie Pub Date : 2026-04-01 Epub Date: 2026-04-08 DOI: 10.1055/a-2703-9729

引用次数: 0

AUO-Studienaktivitäten beim Prostatakarzinom. 前列腺癌研究。

IF 0.4 4区医学

Aktuelle Urologie Pub Date : 2026-04-01 Epub Date: 2026-04-08 DOI: 10.1055/a-2826-4012

引用次数: 0

Does Preoperative Renal Tumour Biopsy Impact Trifecta Achievement in Partial Nephrectomy? 术前肾肿瘤活检是否会影响肾部分切除术的三连胜？

IF 0.5 4区医学

Aktuelle Urologie Pub Date : 2026-04-01 Epub Date: 2024-11-27 DOI: 10.1055/a-2448-1029

Muhammed Fatih Simsekoglu, Muhammet Demirbilek, Ahmet Vural, Ugur Aferin, Burcin Tunc, Sinharib Citgez, Cetin Demirdag

{"title":"Does Preoperative Renal Tumour Biopsy Impact Trifecta Achievement in Partial Nephrectomy?","authors":"Muhammed Fatih Simsekoglu, Muhammet Demirbilek, Ahmet Vural, Ugur Aferin, Burcin Tunc, Sinharib Citgez, Cetin Demirdag","doi":"10.1055/a-2448-1029","DOIUrl":"10.1055/a-2448-1029","url":null,"abstract":"We aimed to evaluate the effect of renal tumour biopsy (RTB) on trifecta criteria achievement in patients treated with open partial nephrectomy (OPN). Patients who were diagnosed with renal cancer and underwent OPN between 2012 and 2023 were retrospectively reviewed. The RTB group consisted of patients who underwent RTB before OPN, while the non-RTB group consisted of those who did not undergo RTB. No matching method was employed since parameters such as tumour size and Padua score were comparable between the two groups. The primary outcome was trifecta achievement, defined as negative surgical margins, warm ischemia time (WIT) <25 minutes, and no complications. Secondary outcomes were the clinicopathologic and survival outcomes of both groups. There were 137 (82.03%) patients in the non-RTB group and 30 (17.96%) patients in the RTB group. The median postoperative follow-up was 45 (24-141) months. The median tumour size was 3.4 (1-7) cm and 3 (1.4-7) cm in the non-RTB group and RTB group, respectively (p=0.282). Seventy-five of the 137 (54.76%) patients in the non-RTB group and 16 of the 30 (53.3%) patients in the RTB group achieved the trifecta criteria (p=0.878). There was no statistically significant difference between the two groups in terms of metastasis-free survival (p=0.332) or overall survival (p=0.359) at 24 months. The rate of intraparenchymal lymphovascular invasion was significantly higher in the RTB group (16.6%) than in the non-RTB group (2.92%) (p=0.013). Our study indicated that trifecta achievement rates were comparable between patients who did and those who did not undergo RTB. Consequently, RTB can be safely performed in renal cancer.","PeriodicalId":7513,"journal":{"name":"Aktuelle Urologie","volume":" ","pages":"202-210"},"PeriodicalIF":0.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142738105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Ureterolyse, Intraperitonealisierung, Ureter-Ileum-Interponat und pyelovesikaler Bypass (Detour) bei Morbus Ormond oder langstreckiger Ureterstriktur. 尿道溶解、腹膜内化、尿道Ileum插值和胆囊搭桥治疗奥蒙德病或缓慢的尿道狭窄。

IF 0.4 4区医学

Aktuelle Urologie Pub Date : 2026-04-01 Epub Date: 2026-04-08 DOI: 10.1055/a-2682-1259

Axel Heidenreich

引用次数: 0

Überaktive Blase nach Rückenmarksläsion: Benefit durch Neuromodulation? 脊髓损伤后膀胱过度活跃：神经调节的好处？

IF 0.4 4区医学

Aktuelle Urologie Pub Date : 2026-04-01 Epub Date: 2026-04-08 DOI: 10.1055/a-2556-1033

引用次数: 0

Dranginkontinenz: Tibialisnerv-Stimulation wirksam und sicher. “胫骨神经刺激是安全有效的”。

IF 0.4 4区医学

Aktuelle Urologie Pub Date : 2026-04-01 Epub Date: 2026-04-08 DOI: 10.1055/a-2642-4077

引用次数: 0

Interventionelle Radiologie in der Urologie – mehrere Wege führen zum Ziel. 泌尿科的介入放射学——有几种方法可以达到这个目的。

IF 0.4 4区医学

Aktuelle Urologie Pub Date : 2026-04-01 Epub Date: 2026-04-08 DOI: 10.1055/a-2703-9756

Martin Schostak, Roman Kloeckner

引用次数: 0